Peptide Synthesis Market Expected to Surpass $1.54 Billion by 2031 Amidst Growing Demand

Growth of the Peptide Synthesis Market

The peptide synthesis market is on a notable trajectory toward growth, projected to climb from $0.98 billion in 2026 to an impressive $1.54 billion by 2031. This development, as highlighted by MarketsandMarkets™, reflects a noteworthy compound annual growth rate (CAGR) of 9.5% during the forecast period.

Key Market Insights

In 2025, North America held the largest share, accounting for approximately 41.8% of the market, primarily driven by a robust pharmaceutical and biotechnology sector that emphasizes peptide drug discovery. Services within this market are estimated to grow at the highest rate of 12.0% during the same period. Additionally, the reagents and consumables segment dominated the market, holding a significant 71.4% share in 2025.

Factors Driving Market Growth

Several factors are propelling the growth of the peptide synthesis market. Pharmaceutical and biotechnology companies are increasingly investing in peptide-based therapeutics and diagnostics, which enhances research applications. Moreover, the escalating development of metabolic, oncology, antimicrobial, and related peptide therapeutics triggers increased demand for peptide synthesizers and ancillary materials.

A notable shift towards automation in peptide synthesis is another key trend. The demand for customized peptides and various modifications has prompted advancements in solid-phase peptide synthesis, leading to enhanced synthesis efficiency and consistency. The advent of high-throughput workflows and improved analytical characterization also contributes to the market's evolution.

Furthermore, the trend towards greener chemistry through optimized workflows is addressing challenges in solvent consumption, reagent efficiency, and synthesis yield. This is crucial as the emphasis on sustainability in research continues to grow.

Shifting Methodologies

The market is witnessing a significant evolution from traditional synthesis methods to advanced production techniques. While solid-phase peptide synthesis remains a staple, biological synthesis techniques are emerging as the fastest-growing segment, particularly for long and complex peptides.

Recombinant platforms and enzymatic synthesis methods provide alternative approaches suited for the biological production of peptides. These methodologies enhance selectivity and minimize harsh reaction conditions, supporting more complex peptide formations.

Regional Market Dynamics

Geographically, North America continues to lead in the peptide synthesis market due to established industry practices and significant R&D spending. The increased activity in peptide drug discoveries further solidifies this region's prominent position in the global market. Major suppliers and custom synthesis providers are flourishing in this landscape, ensuring local access to advanced peptide synthesis technologies.

Investments and Acquisitions

As the market expands, strategic investments are on the rise as companies enhance their capabilities in peptide synthesis and purification. The acquisition of PolyPeptide Group AG by Samsung Biologics for $1.83 billion is an example of strategic growth aimed at diversifying capabilities in peptide-based active pharmaceutical ingredients (APIs).

Conclusion

The outlook for the peptide synthesis market remains bright, underpinned by increasing investments and advancements in synthesis technologies. The growing demand for diverse peptide formats and therapeutic applications signifies substantial growth opportunities ahead. As the industry shifts towards greater complexity and customization, stakeholders must remain agile to capitalize on this evolving market landscape.

Overall, the peptide synthesis market is poised for significant growth in the coming years, with emerging technologies and regional dynamics shaping the competitive landscape. Understanding market trends and drivers will be essential as companies navigate this promising arena.